KeyCorp Issues Pessimistic Forecast for Doximity (NASDAQ:DOCS) Stock Price

Doximity (NASDAQ:DOCS) had its price objective dropped by equities researchers at KeyCorp from $70.00 to $65.00 in a research note issued on Wednesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. KeyCorp’s price target would suggest a potential upside of 18.33% from the stock’s current price.

A number of other brokerages also recently issued reports on DOCS. Stephens started coverage on shares of Doximity in a research report on Friday, December 20th. They issued an “equal weight” rating and a $55.00 price objective for the company. Evercore ISI upped their target price on Doximity from $34.00 to $45.00 and gave the company an “in-line” rating in a report on Tuesday, October 8th. Canaccord Genuity Group downgraded Doximity from a “buy” rating to a “hold” rating and increased their price target for the company from $40.00 to $60.00 in a research report on Wednesday, November 13th. Baird R W raised Doximity to a “strong-buy” rating in a research report on Tuesday, September 17th. Finally, Bank of America raised their target price on Doximity from $54.00 to $57.00 and gave the company a “neutral” rating in a research report on Monday. Thirteen equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Doximity presently has a consensus rating of “Hold” and an average target price of $53.00.

Doximity Trading Down 1.0 %

Shares of NASDAQ:DOCS opened at $54.93 on Wednesday. The stock has a market cap of $10.25 billion, a PE ratio of 63.14, a price-to-earnings-growth ratio of 4.16 and a beta of 1.38. The stock’s fifty day simple moving average is $52.88 and its two-hundred day simple moving average is $41.42. Doximity has a 1-year low of $22.96 and a 1-year high of $61.75.

Institutional Trading of Doximity

Hedge funds and other institutional investors have recently bought and sold shares of the company. FMR LLC grew its position in shares of Doximity by 30.5% during the 3rd quarter. FMR LLC now owns 6,837,733 shares of the company’s stock valued at $297,920,000 after purchasing an additional 1,598,602 shares in the last quarter. William Blair Investment Management LLC grew its position in Doximity by 15.8% during the second quarter. William Blair Investment Management LLC now owns 6,404,068 shares of the company’s stock worth $179,122,000 after buying an additional 873,682 shares in the last quarter. Clearbridge Investments LLC raised its holdings in shares of Doximity by 7.1% in the 2nd quarter. Clearbridge Investments LLC now owns 5,853,035 shares of the company’s stock valued at $163,709,000 after acquiring an additional 387,200 shares in the last quarter. State Street Corp boosted its position in shares of Doximity by 2.5% during the 3rd quarter. State Street Corp now owns 3,693,982 shares of the company’s stock valued at $160,947,000 after acquiring an additional 88,922 shares during the last quarter. Finally, Geode Capital Management LLC grew its holdings in shares of Doximity by 19.8% during the third quarter. Geode Capital Management LLC now owns 2,856,984 shares of the company’s stock worth $124,503,000 after purchasing an additional 472,565 shares in the last quarter. Institutional investors own 87.19% of the company’s stock.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.